Adverse events should be reported.
Reporting forms and information can be found at or search for MHRA Yellow Card in Google Play or Apple App Store.
Adverse events should also be reported to Ipsen via email at or phone on 01753 627777.
A link to the prescribing information can be found in the header.

Dysport® (Clostridium botulinum type A toxin-haemagglutinin complex) is indicated for symptomatic treatment of focal spasticity of:

  • Upper limbs in adults
  • Lower limbs in adults affecting the ankle joint

Please click here to see the full therapeutic indications.

Adult Spasticity

Making sense of the changing NHS and funding flows

12 minutes

Dr Judy Willits discusses how the NHS payment scheme has evolved and what the changes could mean for your botulinum toxin services.


Navigating the Switch between BoNT-As: The North Staffordshire Rehabilitation Centre Experience

10 minutes

Dr Clive Bezzina shares his personal experience switching between BoNT-As within his spasticity service, and the outcomes seen for both the patients and the service.